Clearly, GPR55 is an exciting, novel, and underexplored receptor around which it may be possible to develop therapies for neuropathic pain [16], osteoporosis [17], [18], cancer [13], [19], [20], and obesity [21]. Here, GPR55 is linked to cancer.